excerpt-***Regardless of whether or not the FDA offers greater clarity after this Friday's public hearing, demand for CBD is exploding ... and doesn't appear to be slowing
Last year, retail sales of CBD products in the U.S. were estimated between $600 million and $2 billion, according to the investment research firm Cowen. By 2025, the group conservatively forecasts sales to reach $16 billion, with health and wellness products leading the way.
It's growth like this that's leading to massive investment gains from CBD-related stocks. For example, take Elixinol Global Limited.
News 
Market Data 
Discover 
